Page 421 - Basic _ Clinical Pharmacology ( PDFDrive )

CHAPTER 23 The Alcohols 407

PREP AR A TIONS A V AIL ABLE

GENERIC NAME AVAILABLE AS GENERIC NAME AVAILABLE AS
DRUGS FOR THE TREATMENT OF ACUTE ALCOHOL DRUGS FOR THE PREVENTION OF ALCOHOL ABUSE
WITHDRAWAL SYNDROME (SEE ALSO CHAPTER 22 Acamprosate calcium Generic, Campral
FOR OTHER BENZODIAZEPINES)
Disulfiram Generic, Antabuse
Chlordiazepoxide HCl Generic, Librium
Naltrexone HCl Generic, Vivitrol, ReVia
Diazepam Generic, Valium DRUGS FOR THE TREATMENT OF ACUTE METHANOL OR
Lorazepam Generic, Ativan ETHYLENE GLYCOL POISONING
Oxazepam Generic, Serax Ethanol Generic
Thiamine HCl Generic Fomepizole Generic, Antizol

REFERENCES Jonas DE et al: Pharmacotherapy for adults with alcohol use disorders in outpa-
Anton RF: Naltrexone for the management of alcohol dependence. N Engl J Med tient settings. A systematic review and meta-analysis. JAMA 2014;311:1889.
2008;359:715. Klatsky AL: Alcohol and cardiovascular diseases. Expert Rev Cardiovasc Ther
2009;7:499.
Anton RF et al: Combined pharmacotherapies and behavioral interventions for
alcohol dependence: The COMBINE study: A randomized controlled trial. Lepik KJ et al: Adverse drug events associated with the antidotes for methanol and
JAMA 2006;295:2003. ethylene glycol poisoning: A comparison of ethanol and fomepizole. Ann
Emerg Med 2009;53:439.
Brent J: Fomepizole for ethylene glycol and methanol poisoning. N Engl J Med
2009;360:2216. Lobo IA, Harris RA: GABA(A) receptors and alcohol. Pharmacol Biochem Behav
2008;90:90.
Brodie MS et al: Ethanol interactions with calcium-dependent potassium channels.
Alcohol Clin Exp Res 2007;31:1625. Mann K et al: Acamprosate: Recent findings and future research directions. Alcohol
Clin Exp Res 2008;32:1105.
Centers for Disease Control and Prevention: Fetal alcohol spectrum disorder.
https://www.cdc.gov/ncbddd/fasd/ Mayfield RD, Harris RA, Schuckit MA: Genetic factors influencing alcohol
dependence. Br J Pharmacol 2008;154:275.
Chan LN, Anderson GD: Pharmacokinetic and pharmacodynamics interactions
with ethanol (alcohol). Clin Pharmacokinet 2014;53:1115. Mitchell JM: Varenicline decreases alcohol consumption in heavy-drinking smok-
ers. Psychopharmacology (Berl) 2012;223:299.
Chen YC et al: Polymorphism of ethanol-metabolism genes and alcoholism: Cor-
relation of allelic variations with the pharmacokinetic and pharmacodynamic National Institutes of Health: National Institute on Alcohol Abuse and Alcoholism.
consequences. Chem Biol Interact 2009;178:2. http://www.niaaa.nih.gov/
Colombo G et al: The cannabinoid CB1 receptor antagonist, rimonabant, as a O’Keefe JH, Bybee KA, Lavie CJ: Alcohol and cardiovascular health: The razor-
promising pharmacotherapy for alcohol dependence: Preclinical evidence. sharp double-edged sword. J Am Coll Cardiol 2007:50:1009.
Mol Neurobiol 2007;36:102. Olson KR et al (editors): Poisoning and Drug Overdose, 7th ed. McGraw-Hill,
Crabbe JC et al: Alcohol-related genes: Contributions from studies with genetically 2017.
engineered mice. Addict Biol 2006;11:195. Patkar OL et al: The effect of varenicline on binge-like ethanol consumption
Das SK, Vasudevan DM: Alcohol-induced oxidative stress. Life Sci 2007;81:177. in mice is β4 nicotinic acetylcholine receptor-independent. Neurosci Lett
2016;633:235.
Edenberg HJ: The genetics of alcohol metabolism: Role of alcohol dehydrogenase
and aldehyde dehydrogenase variants. Alcohol Res Health 2007;30:5. Qiang M, Denny AD, Ticku MK: Chronic intermittent ethanol treatment selec-
tively alters N-methyl-D-aspartate receptor subunit surface expression in
Heffernan TM: The impact of excessive alcohol use on prospective memory: cultured cortical neurons. Mol Pharmacol 2007;72:95.
A brief review. Curr Drug Abuse Rev 2008;1:36. Seitz HK, Stickel F: Molecular mechanisms of alcohol-mediated carcinogenesis.
Hendricson AW et al: Aberrant synaptic activation of N-methyl-D-aspartate Nat Rev Cancer 2007;7:599.
receptors underlies ethanol withdrawal hyperexcitability. J Pharmacol Exp
Ther 2007;321:60. Srisurapanont M, Jarusuraisin N: Opioid antagonists for alcohol dependence.
Cochrane Database Syst Rev 2005;1:CD001867.
Johnson BA: Pharmacotherapy for alcohol use disorder. In: Saitz R (editor):
UpToDate. Waltham, MA. http://www.uptodate.com/contents/ Wolf FW, Heberlein U: Invertebrate models of drug abuse. J Neurobiol
pharmacotherapy-for-alcohol-use-disorder 2003;54:161.
Johnson BA: Update on neuropharmacological treatments for alcoholism: Scientific
basis and clinical findings. Biochem Pharmacol 2008;75:34.